China regulator confesses invalid tests; GE recalls dangerous ventilators; Pfizer recalls cough syrup;

> The FDA says Pfizer ($PFE) is voluntarily recalling its Robitussin DM cough syrup because of dosing inaccuracies for children. Story

> The FDA has assigned its most serious designation to GE Healthcare's ($GE) recall of Aestiva/5 7900, warning that a flaw in the devices could lead to circulatory shock and death. Story

> The FDA smacked Siemens Healthcare with the second warning letter in a month concerning quality and manufacturing issues with some of its diagnostics products. Story

> An FDA 483 inspection of Exemplar Pharmaceuticals of Fall River, MA, found the aerosol drugmaker lacked adequate controls to ensure consistent mixtures of its products. FDA report

And Finally... A Chinese agency acknowledged that invalid testing led it to say that vanillin had been found in baby formula from companies including Mead Johnson. Story

Suggested Articles

Fujifilm Diosynth Biotechnologies last year committed 10 billion yen toward its manufacturing operations. It has now kicked off one of those projects.

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.